Insulin resistance as a mechanism of adaptation during human evolution;La resistencia a la insulina como mecanismo de adaptación durante la evolución humana

Endocrinologia y Nutricion

Volumn 57, Issue 8, 2010, Pages 381-390

  Ricart, W ^a   Fernandez Real J M ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Diabetes mellitus; Evolution; Insulin resistance; Microbiota; Obesity

Indexed keywords

INSULIN;

DIET RESTRICTION; FOOD INTAKE; INFECTION; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; SHORT SURVEY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BIOLOGICAL EVOLUTION; BRAIN; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; ENERGY METABOLISM; FEMALE; HUMANS; IMMUNE SYSTEM; INFECTION; INFLAMMATION; INSULIN RESISTANCE; INTESTINES; MALE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; STARVATION; SURVIVAL; SYMBIOSIS;

EID: 77957252375     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2010.05.003     Document Type: Short Survey

References (146)

1. Garruto R.M. A commentary on neuronal degeneration and cell death in Guam ALS and PD: An evolutionary process of understanding. Curr Alzheimer Res 2006, 3:397-401.
2. Olson E.N. Gene regulatory networks in the evolution and development of the heart. Science 2006, 313:1922-1927.
3. Mingomataj E.C., Rudzeviciene O. From latent incubation launched into hostile symptomatic pathology: A probable survival strategy for common respiratory infectious agents. Med Hypotheses 2007, 68:397-400.
4. Wasserzug O., Blum S., Klement E., Lejbkowicz F., Miller-Lotan R., Levy A.P. Haptoglobin 1-1 genotype and the risk of life-threatening Streptococcus infection: Evolutionary implications. J Infect 2007, 54:410.
5. Gleicher N., Barad D. An evolutionary concept of polycystic ovarian disease: Does evolution favour reproductive success over survival?. Reprod Biomed Online 2006, 12:587-589.
6. Ayuk P.T. Hypertensive disorders of pregnancy are an evolutionary adaptation to mitigate the reproductive consequences of the human physique. Med Hypotheses 2006, 67:796-801.
7. Mackay I.R. The etiopathogenesis of autoimmunity. Semin Liver Dis 2005, 25:239-250.
8. Vernier P., Moret F., Callier S., Snapyan M., Wersinger C., Sidhu A. The degeneration of dopamine neurons in Parkinson's disease: Insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci 2004, 1035:231-249.
9. Straub R.H., Besedovsky H.O. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J 2003, 17:2176-2183.
10. Cohen S. Diffuse pulmonary hemorrhage: Evolutionary 'flaw' or consequence of evolutionary progress?. Am J Med Sci 2002, 323:130-139.
11. Sapolsky R.M., Finch C.E. Alzheimer's disease and some speculations about the evolution of its modifiers. Ann N Y Acad Sci 2000, 924:99-103.
12. Connor A., Weiss K.M., Weeks S.C. Evolutionary models of quantitative disease risk factors. Hum Biol 1993, 65:917-940.
13. Pijnenborg R., Vercruysse L., Hanssens M. Fetal-maternal conflict, trophoblast invasion, preeclampsia, and the red queen. Hypertens Pregnancy 2008, 27:183-196.
14. Silva J.E., Bianco S.D. Thyroid-adrenergic interactions: Physiological and clinical implications. Thyroid 2008, 18:157-165.
15. Armanini D., Fiore C. Some considerations about evolution of idiopathic primary aldosteronism. J Endocrinol Invest 2009, 32:623-625.
16. Dierssen M., Herault Y., Estivill X. Aneuploidy: From a physiological mechanism of variance to Down syndrome. Physiol Rev 2009, 89:887-920.
17. Eisen A. Amyotrophic lateral sclerosis-evolutionary and other perspectives. Muscle Nerve 2009, 40:297-304.
18. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: Implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009, 16:300-317.
19. Tan C.S., Bodenmiller B., Pasculescu A., Jovanovic M., Hengartner M.O., Jørgensen C., et al. Comparative analysis reveals conserved protein phosphorylation networks implicated in multiple diseases. Scin Signal 2009, 2:ra39.
20. Hilaire G., Dutschmann M. Foreword: Respiratory rhythmogenesis. Respir Physiol Neurobiol 2009, 168:1-3.
21. Preston B.T., Capellini I., McNamara P., Barton R.A., Nunn C.L. Parasite resistance and the adaptive significance of sleep. BMC Evol Biol 2009, 9:7.
22. Wander K., Shell-Duncan B., McDade T.W. Evaluation of iron deficiency as a nutritional adaptation to infectious disease: An evolutionary medicine perspective. Am J Hum Biol 2009, 21:172-179.
23. Obesity: Preventing and Managing the global Epidemic. World Health Organ Tech Rep Ser 894 2000, World Health Organization, World Health Organization, Geneva.
24. James W.P. WHO recognition of the global obesity epidemic. Int J Obes (Lond) 2008, 32:S120-S126.
25. Intenational Diabetes Federation (IDF). Diabetes Atlas (e-Atlas); 2008. [consultado 15/2/2010]. Disponible en: http://www.eatlas.idf.org/index2983.html.
26. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
27. Seidell J.C. Obesity, insulin resistance and diabetes--a worldwide epidemic. Br J Nutr 2000, 83:S5-S8.
28. Kelly T., Yang W., Chen C.S., Reynolds K., He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008, 32:1431-1437.
29. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
30. Dawkins R. The extended Phenotype: The Long Reach of the Gene. Oxford: Oxford University Press. p. xiii. ISBN 0-19-288051-9.
31. Bennet DC. La peligrosa idea de Darwin: evolución y signifcados de la vida. 1999. Círculo de Lectores. Galaxia Gutenberg, Barcelona.
32. Fernández-Real J.M., Ricart W. Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 1999, 42:1367-1374.
33. Neel J.V. Diabetes mellitus: A "thrifty" genotype rendered detrimental by "progress"?. Am J Hum Genet 1962, 14:353-362.
34. Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019-1022.
35. Dulloo A.G. Thrifty energy metabolism in catch-up growth trajectories to insulin and leptin resistance. Best Pract Res Clin Endocrinol Metab 2008, 22:155-171.
36. Dulloo A.G. Regulation of fat storage via suppressed thermogenesis: A thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity. Horm Res 2006, 65:90-97.
37. Bhargava S.K., Sachdev H.S., Fall C.H., Osmond C., Lakshmy R., Barker D.J., et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004, 350:865-875.
38. Barker D.J., Osmond C., Forsén T.J., Kajantie E., Eriksson J.G. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005, 353:1802-1809.
39. Ibáñez L., Ong K., Dunger D.B., De Zegher F. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab 2006, 91:2153-2158.
40. Ibáñez L., Suárez L., Lopez-Bermejo A., Díaz M., Valls C., De Zegher F. Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight. J Clin Endocrinol Metab 2008, 93:925-928.
41. Whincup P.H., Kaye S.J., Owen C.G., Huxley R., Cook D.G., Anazawa S., et al. Birth weight and risk of type 2 diabetes: A systematic review. JAMA 2008, 300:2886-2897.
42. Summermatter S., Mainieri D., Russell A.P., Seydoux J., Montani J.P., Buchala A., et al. Thrifty metabolism that favors fat storage after caloric restriction: A role for skeletal muscle phosphatidylinositol-3-kinase activity and AMP-activated protein kinase. FASEB J 2008, 22:774-785.
43. Major G.C., Doucet E., Trayhurn P., Astrup A., Tremblay A. Clinical significance of adaptive thermogenesis. Int J Obes (Lond) 2007, 31:204-212.
44. Speakman J.R. Obesity: The integrated roles of environment and genetics. J Nutr 2004, 134:2090S-2105S.
45. Mercer J.G., Speakman J.R. Hypothalamic neuropeptide mechanisms for regulating energy balance: From rodent models to human obesity. Neurosci Biobehav Rev 2001, 25:101-116.
46. Blundell J.E., Gillett A. Control of food intake in the obese. Obes Res 2001, 9:263S-270S.
47. Ni Mhurchu C., Parag V., Nakamura M., Patel A., Rodgers A., Lam T.H. Body mass index and risk of diabetes mellitus in the Asia-Pacific region. Asia Pac J Clin Nutr 2006, 15:127-133. Asia Pacific Cohort Studies Collaboration.
48. Kumanyika S.K. Obesity in minority populations: An epidemiologic assessment. Obes Res 1994, 2:166-182.
49. Okihiro M., Harrigan R. An overview of obesity and diabetes in the diverse populations of the Pacific. Ethn Dis 2005, 15:S71-S80.
50. Fernández-Real J.M., Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003, 24:278-301.
51. Watve M.G., Yajnik C.S. Evolutionary origins of insulin resistance: A behavioral switch hypothesis. BMC Evol Biol 2007, 7:61.
52. Sinervo B., Svensson E., Comendant T. Density cycles and an offspring quantity and quality game driven by natural selection. Nature 2000, 406:985-988.
53. Winick M., Rosso P., Waterlow J.C. Cellular growth of cerebrum, cerebellum and brain stem in normal and merasmic children. Exp Neurol 1970, 26:393-400.
54. Winick M. Malnutrition and brain development. J Pediatr 1969, 74:667-679.
55. Watve M.G., Shejval V., Sonawane C., Rahalkar M., Matapurkar A., Shouche Y., et al. The 'K' selected oligophilic bacteria: A key to uncultured diversity?. Cur Sci 2000, 78:1535-1542.
56. Cranston I., Marsden P., Matyka K., Evans M., Lomas J., Sonksen P., et al. Regional differences in cerebral blood flowand glucose utilization in diabetic man: The effect of insulin. J of Cerebral Blood Flow & Metab 1998, 18:130-140.
57. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., et al. Role of neuronal insulin resistance in neurodegenerative diseases. PNAS 2004, 101:3100-3105.
58. Zhao W.-Q., Alkon D.L. Role of insulin and insulin receptor in learning and memory. Mol and Cell Endocrinol 2001, 177:125-134.
59. Elias P.K., Elias M.F., D'Agostino R.B., Sullivan L.M., Wolf P.A. Serum cholesterol and cognitive performance in the Framingham heartstudy. Psychosomatic Med 2005, 67:24-30.
60. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004, 61:661-666.
61. Rasgon N., Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: Review and hypothesis. J Gerontol 2004, 59A:178-183.
62. Shiiki T., Ohtsuki S., Kurihara A., Naganuma H., Nishimura K., Tachikawa M., et al. Brain insulin impairs Amyloid-Β(1-40) clearance from the brain. J Neurosci 2004, 24:9632-9637.
63. Ryan C.M., Geckle M. Why is learning and memory dysfunction in type 2 diabetes limited to older adults. Diabetes Metab Res Rev 2000, 16:308-315.
64. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M., et al. Brain insulin receptors and spatial memory. J Biol Chem 1999, 274:34893-34902.
65. De la Monte S.M. Insulin resistance and Alzheimer's disease. BMB Rep 2009, 42:475-481.
66. S Roriz-Filho J., Sá-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L., et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792:432-443.
67. Li H., Lelliott C., Håkansson P., Ploj K., Tuneld A., Verolin-Johansson M., et al. Intestinal, adipose, and liver inflammation in diet-induced obese mice. Metabolism 2008, 57:1704-1710.
68. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
69. Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
70. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
71. Esteve E., Ricart W., Fernández-Real J.M. Dyslipidemia and inflammation: An evolutionary conserved mechanism. Clin Nutr 2005, 24:16-31.
72. Fernández-Real J.M., Pickup J.C. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2008, 19:10-16.
73. Janeway C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992, 13:11-16.
74. Murphy T.J., Paterson H.M., Mannick J.A., Lederer J.A. Injury, sepsis, and the regulation of Toll-like receptor responses. J Leukoc Biol 2004, 75:400-407.
75. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008, 8:923-934.
76. Søndergaard L. Homology between the mammalian liver and the Drosophila fat body. Trends Genet 1993, 9:193.
77. Chung S., Lapoint K., Martinez K., Kennedy A., Boysen Sandberg M., McIntosh MK Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 2006, 147:5340-5351.
78. Charrière G., Cousin B., Arnaud E., André M., Bacou F., Penicaud L., et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003, 278:9850-9855.
79. Khazen W., M'bika J.P., Tomkiewicz C., Benelli C., Chany C., Achour A., et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett 2005, 579:5631-5634.
80. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
81. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: Insights into Medzhitov R Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145.
82. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
83. Davis J.E., Gabler N.K., Walker-Daniels J., Spurlock M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 2008, 16:1248-1255.
84. Vitseva O.I., Tanriverdi K., Tchkonia T.T., Kirkland J.L., McDonnell M.E., Apovian C.M., et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008, 16:932-937.
85. Suganami T., Mieda T., Itoh M., Shimoda Y., Kamei Y., Ogawa Y. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 2007, 354:45-49.
86. Fernández-Real J.M., Broch M., Vendrell J., Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003, 26:1362-1368.
87. Fernández-Real J.M., López-Bermejo A., Vendrell J., Ferri M.J., Recasens M., Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006, 29:1058-1064.
88. Taniguchi CM, Emanuelli B, Kahn CR Critical nodes in signalling pathways: insights into insulin action. Nature Rev Mol Cell Biol 2006, 7:85-96.
89. Rasmussen S.B., Reinert L.S., Paludan S.R. Innate recognition of intracellular pathogens: Detection and activation of the first line of defense. APMIS 2009, 117:323-337.
90. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009, 22:240-273.
91. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009, 21:317-337.
92. Mathews R.J., Sprakes M.B., McDermott M.F. NOD-like receptors and inflammation. Arthritis Res Ther 2008, 10:228.
93. Megia A., Gallart L., Fernández-Real J.M., Vendrell J., Simón I., Gutierrez C., et al. Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. J Clin Endocrinol Metab 2004, 89:5081-5087.
94. Fernández-Real J.M., Straczkowski M., Vendrell J., Soriguer F., Pérez del Pulgar S., Gallart L, et al. Protection from inflammatory disease in insulin resistance: The role of mannan-binding lectin. Diabetologia 2006, 49:2402-2411.
95. Manco M., Fernández-Real J.M., Equitani F., Vendrell J., Valera Mora M.E., Nanni G., et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 2007, 92:483-490.
96. Ibernon M., Moreso F., Moreno J.M., Bestard O., Cruzado J.M., Grinyó J.M., et al. Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation 2009, 88:272-278.
97. Goldberg R.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009, 94:3171-3182.
98. Devaraj S., Singh U., Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009, 20:182-189.
99. Ghanim H., Abuaysheh S., Sia C.L., Korzeniewski K., Chaudhuri A., Fernández Real J.M., et al. Increase in plasma endotoxin concentrations and the expression of Toll like receptors and suppressor of cytokine signaling-3 in mononuclear cells following a high fat high carbohydrate meal: Implications for insulin resistance. Diabetes Care 2010, En prensa.
100. Gubern C., López-Bermejo A., Biarnés J., Vendrell J., Ricart W., Fernández-Real J.M. Natural antibiotics and insulin sensitivity: The role of bactericidal/permeability-increasing protein. Diabetes 2006, 55:216-224.
101. Fernández-Real J.M., López-Bermejo A., Castro A., Broch M., Peñarroja G., Vendrell J., et al. Opposite relationship between circulating soluble CD14 concentration and endothelial function in diabetic and nondiabetic subjects. Thromb Haemost 2005, 94:615-619.
102. Fernández-Real J.M., Broch M., Richart C., Vendrell J., López-Bermejo A., Ricart W. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 2003, 88:1780-1784.
103. Chacón M.R., Fernández-Real J.M., Richart C., Megía A., Gómez J.M., Miranda M., et al. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study. Obesity (Silver Spring) 2007, 15:664-672.
104. Fernández-Real J.M., López-Bermejo A., Broch M., Vendrell J., Richart C., Ricart W. Circulating soluble CD14 monocyte receptor is associated with increased alanine aminotransferase. Clin Chem 2004, 50:1456-1458.
105. Fernández-Real J.M., García-Fuentes E., Moreno-Navarrete J.M., Murri-Pierri M., Garrido-Sánchez L., Ricart W., et al. Fat overload induces changes in circulating lactoferrin that are associated with postprandial lipemia and oxidative stress in severely obese subjects. Obesity (Silver Spring) 2010, En prensa.
106. Moreno-Navarrete J.M., Ortega F.J., Ricart W., Fernández-Real J.M. Lactoferrin increases (172Thr) AMPK phosphorylation and insulin-induced (p473Ser) AKT while impairing adipocyte differentiation. Int J Obes (Lond) 2009, 33:991-1000.
107. Moreno-Navarrete J.M., Ortega F.J., Bassols J., Ricart W., Fernández-Real J.M. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 2009, 94:4036-4044.
108. Fernández-Real J.M., Moreno J.M., Ricart W. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes 2008, 57:1918-1925.
109. Moreno-Navarrete J.M., Ortega F.J., Bassols J., Castro A., Ricart W., Fernández-Real J.M. Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem 2008, 54:301-309.
110. Rasouli N., Yao-Borengasser A., Varma V., Spencer H.J., McGehee R.E., Peterson C.A., et al. Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol 2009, 29:1328-1335.
111. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103:1057-1063.
112. Ortega Martínez de Victoria E., Xu X., Koska J., Francisco A.M., Scalise M., Ferrante A.W., et al. Macrophage content in subcutaneous adipose tissue: Associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes 2009, 58:385-393.
113. Todd D.J., Lee A.H., Glimcher L.H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nature Rev Immunol 2008, 8:663-674.
114. Reiling J.H., Sabatini D.M. Stress and mTORture signaling. Oncogene 2006, 25:6373-6383.
115. Erbay E., Cao H., Hotamisligil G.S. Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome. Curr Atheroscler Rep 2007, 9:222-229.
116. Makowski L., Brittingham K.C., Reynolds J.M., Suttles J., Hotamisligil G.S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 2005, 280:12888-12895.
117. Makowski L., Hotamisligil G.S. Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004, 134:2464S-2468S.
118. Furuhashi M., Fucho R., Görgün C.Z., Tuncman G., Cao H., Hotamisligil G.S. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008, 118:2640-2650.
119. Chandra R.K. Immune response in overnutrition. Cancer Res 1981, 41:3795-3796.
120. Longo V.D., Finch C.E. Evolutionary medicine: From dwarf model systems to healthy centenarians?. Science 2003, 299:1342-1346.
121. Fernández-Real J.M., López-Bermejo A., Vendrell J., Ferri M.J., Recasens M., Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006, 29:1058-1064.
122. Fernández-Real J.M., Ferri M.J., Vendrell J., Ricart W. Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring) 2007, 15:245-252.
123. Nabipour I., Vahdat K., Jafari S.M., Pazoki R., Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study. Cardiovasc Diabetol 2006, 5:25.
124. Wang C.C., Hsu C.S., Liu C.J., Kao J.H., Chen D.S. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008, 23:779-782.
125. Thjodleifsson B., Olafsson I., Gislason D., Gislason T., Jögi R., Janson C. Infections and obesity: A multinational epidemiological study. Scand J Infect Dis 2008, 40:381-386.
126. Xu J., Gordon J.I. Inaugural article: Honor thy symbionts. PNAS 2003, 100:10452-10459.
127. Strober W., Fuss I.J., Blumberg R.S. The immunology of mucosal models of inflammation. Ann Rev Immunology 2002, 20:495-549.
128. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
129. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
130. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. PNAS 2004, 101:15718-15723.
131. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. PNAS 2005, 102:11070-11075.
132. Bäckhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. PNAS 2007, 104:979-984.
133. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449:804-810.
134. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: Implications for the pathogenesis of obesity. J Neurosci 2009, 29:359-370.
135. Davis J.E., Gabler N.K., Walker-Daniels J., Spurlock M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 2008, 16:1248-1255.
136. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
137. Kuhn S.L., Stiner M.C. The Antiquity of Hunter-gatherers. Hunter-gatherers: An interdisciplinary perspective 2001, Cambridge University Press, Cambridge, p. 99-142. C. Panter-Brick, P. Rowley-Conwy, R. Layton (Eds.).
138. Freed D.L.J. Lectins in food: Their importance in health and disease. J Nutr Med 1991, 2:45-65.
139. Wang Q., Yu L.G., Campbell B.J., Milton J.D., Rhodes J.M. Identification of intact peanut lectin in peripheral venous blood. Lancet 1998, 352:1831-1832.
140. Cordain L., Toohey L., Smith M.J., Hickey M.S. Modulation of immune function by dietary lectins in rheumatoid arthritis. Br J Nutr 2000, 83:207-217.
141. Gabor F., Klausegger U., Wirth M. The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145. Int J Pharm 2001, 221:35-47.
142. Davis H.R., Glagov S. Lectin binding to distinguish cell types in fixed atherosclerotic arteries. Atherosclerosis 1986, 61:193-203.
143. Jönsson T., Olsson S., Ahrén B., Bøg-Hansen T.C., Dole A., Lindeberg S. Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance?. BMC Endocr Disord 2005, 5:10.
144. Jönsson T., Ahrén B., Pacini G., Sundler F., Wierup N., Steen S., et al. A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr Metab (Lond) 2006, 3:39.
145. Lindeberg S., Jönsson T., Granfeldt Y., Borgstrand E., Soffman J., Sjöström K., et al. A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia 2007, 50:1795-1807.
146. Jönsson T., Granfeldt Y., Ahrén B., Branell U.C., Pålsson G., Hansson A., et al. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: A randomized cross-over pilot study. Cardiovasc Diabetol 2009, 8:35.